Innovative perspectives of immunotherapy in head and neck cancer. From relevant scientific rationale to effective clinical practice

Lalami, Yassine; Awada, Ahmad

doi:doi/10.1016/j.ctrv.2016.01.001

Recherche avancée | Historique de recherche Mon DI-fusion | À propos de DI-fusion | Contact |

Citer

Innovative perspectives of immunotherapy in head and neck cancer. From relevant scientific rationale to effective clinical practice

par Lalami, Yassine

;Awada, Ahmad

Référence Cancer treatment reviews, 43, page (113-123)
Publication Publié, 2016

Article révisé par les pairs

Résumé :

It is now well established that head and neck cancer carcinogenesis is characterized by genetic instability and several immune defects, leading to unique host-tumor interactions. In such condition, recent improved comprehension and relevant findings could lead to identification of innovative molecular therapeutic targets, achieving considerable clinical and translational research. This review aims to summarize and to highlight most recent and relevant scientific rationale in this era of immunotherapy revival, and to correlate it to the near future clinical practice for the management of this challenging disease.

Documents en relation

DI-fusion

Phase Ia dose-escalation trial with the BET protein inhibitor BI 894999 in patients with advanced or metastatic solid tumours
par Schöffski, Patrick , Machiels, Jean Pascal , Rottey, Sylvie , Sadrolhefazi, Behbood , Musa, Hanny , Marzin, Kristell , Awada, Ahmad
Publication 2023-09
Impact of scatter correction on personalized dosimetry in selective internal radiotherapy using 166Ho‐PLLA: a single‐center study including Monte‐Carlo simulation, phantom and patient imaging
par Collette, Benoit , Mannie-Corbisier, Marie , Bucalau, Ana-Maria , Pauly, Nicolas , Verset, Gontran , Moreno-Reyes, Rodrigo , Flamen, Patrick , Trotta, Nicola
Publication 2024-04-02
ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy
par Soumoy, Laura , Genbauffe, Aline , Mouchart, Lena , Sperone, Alexandra , Trelcat, Anne , Mukeba-Harchies, Léa , Wells, Mathilde , Blankert, Bertrand , Najem, Ahmad , Ghanem, Ghanem Elias , Saussez, Sven , Journé, Fabrice
Publication 2024-12
La planification préalable des soins : enjeux et défis pour les soignants en oncologie
par Libert, Yves
Publication 2024-04-02
[18F]FDG PET/CT–Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study
par Chan, David Lok Hang D.L. , Hayes, Aimee A.R. , Karfis, Ioannis , Conner, Alice , Mileva, Magdalena , Bernard, Elizabeth , Schembri, Geoffrey , Navalkissoor, Shaunak , Gnanasegaran, Gopinath , Pavlakis, Nick , Marin, Clementine , Vanderlinden, Bruno , Flamen, Patrick , Roach, Paul , Caplin, Martyn Evan , Toumpanakis, Christos , Bailey, Dale D.L.
Publication 2024-02

Référencement	Visibilité	Pérennité	Facilité
Les publications encodées constituent la bibliographie académique de l'Université.	Les documents déposés sont indexés par les moteurs de recherche (Google Scholar,…).	Les documents déposés en open-access sont archivés au sein du réseau de préservation SAFE-PLN (www.safepln.org).	Les listes de publications sont compatibles avec le CV-ULB, le FNRS et accessibles sur le web.